Unique cyclophosphamide doses in male mice decrease the spermatic quality and germinal epithelium
DOI:
https://doi.org/10.15381/rpb.v19i2.840Keywords:
Cyclophosphamide, C57BL mouse, toxicity, fertility, semen analysis.Abstract
Cyclophosphamide (CP) is an alkylating agent commonly used as antineoplastic and immunosuppressive drug. The use of CP in the treatment of cancer is limited due to its severe toxicity. The aim of this study was to determine theeffectof a single dose of CP (220 mg/kg b.w.) intraperitoneally administered after 7 days,on sperm parameter and male germinal epithelium in mice. We used C57BL mature male mice divided into 2 groups (n= 10); Control Group (C): 0.9% and NaCl Treatment group (T): CP to 220 mg/kg cw in single dose. After 8 days all the mice were euthanized. The weight of the body and reproductive organs: testis, epididymis and vas deferens, were registered. Concentration, motility and sperm morphology and testicular histology were evaluated. Significant differences were found in body weight (student t-test p<0.05) (T: 20.18±1.9 g vs C: 23.35±1.2 g; testicular weight (T: 59.71±5.40 mg vs C: 72.90±2.8 mg), epididymis tail weight (T: 9.83 ± 1.54 vs C: 14.30 ± 2.20, vas deferens weight (T: 8.27±0.80 mg vs C: 10.61±0.76 mg respectively), concentration (T: 9.2±1.9 vs. C: 14.4±3.3 x 106 sperm / mL), progressive motility (T: 25.98±6,4% vs C: 42.96±5.2%). There wasn´t significant differences in sperm morphology (student t-test p<0.05), but there was a significant increase in abnormal tail and immature sperm (T vs. C: 36,24±7,8% vs 31.73±9,1%; 27,44±2,1% vs 18,51±8,6%; respectively) and also severe damage seminiferous tubules was observed. We conclude that single dose of CP (220mg/kg b.w.) decreased the reproductive quality of male mice.Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2012 Láyonal Acosta, Víctor Núñez, Jonathan Vásquez, José Pino, Betty Shiga
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
AUTHORS RETAIN THEIR RIGHTS:
a. Authors retain their trade mark rights and patent, and also on any process or procedure described in the article.
b. Authors retain their right to share, copy, distribute, perform and publicly communicate their article (eg, to place their article in an institutional repository or publish it in a book), with an acknowledgment of its initial publication in the Revista Peruana de Biologia.
c. Authors retain theirs right to make a subsequent publication of their work, to use the article or any part thereof (eg a compilation of his papers, lecture notes, thesis, or a book), always indicating its initial publication in the Revista Peruana de Biologia (the originator of the work, journal, volume, number and date).